Lexapro and Dapagliflozin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among 2 people who take Lexapro and Dapagliflozin. Common interactions include abdominal pain upper among males.
The phase IV clinical study analyzes what interactions people who take Lexapro and Dapagliflozin have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2 people who take Lexapro and Dapagliflozin together, and have interactions are studied.
What is Lexapro?
Lexapro has active ingredients of escitalopram oxalate. It is used in depression. Currently, eHealthMe is studying from 88,414 Lexapro users.
What is Dapagliflozin?
Dapagliflozin has active ingredients of dapagliflozin. Currently, eHealthMe is studying from 1,191 Dapagliflozin users.
Number of Lexapro and Dapagliflozin reports submitted per year:
Common Lexapro and Dapagliflozin drug interactions by gender *:
female:
n/a
male:
- Abdominal pain upper
- Cellulitis
- Drug effect decreased
- Drug ineffective
- Pain
Common Lexapro and Dapagliflozin drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Cellulitis
- Drug effect decreased
- Drug ineffective
- Pain
* Approximation only. Some reports may have incomplete information.
Do you take Lexapro and Dapagliflozin?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
Related studies
Drug side effects by duration, gender and age:
- Lexapro side effects (88,414 reports)
- Dapagliflozin side effects (1,191 reports)
Common Lexapro drug interactions:
- Lexapro and Aspirin: 8,200 reports
- Lexapro and Xanax: 6,010 reports
- Lexapro and Synthroid: 5,815 reports
- Lexapro and Wellbutrin: 5,719 reports
- Lexapro and Lipitor: 5,330 reports
- Lexapro and Nexium: 5,264 reports
- Lexapro and Lisinopril: 5,215 reports
- Lexapro and Vitamin d: 5,181 reports
- Lexapro and Prednisone: 5,174 reports
- Lexapro and Gabapentin: 5,129 reports
Browse interactions between Lexapro and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Dapagliflozin drug interactions:
- Dapagliflozin and Metformin: 688 reports
- Dapagliflozin and Simvastatin: 164 reports
- Dapagliflozin and Metformin hydrochloride: 147 reports
- Dapagliflozin and Ramipril: 143 reports
- Dapagliflozin and Gliclazide: 133 reports
- Dapagliflozin and Aspirin: 131 reports
- Dapagliflozin and Acetylsalicylic acid: 113 reports
- Dapagliflozin and Furosemide: 112 reports
- Dapagliflozin and Amlodipine: 108 reports
Browse interactions between Dapagliflozin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on escitalopram oxalate and dapagliflozin (the active ingredients of Lexapro and Dapagliflozin, respectively), and Lexapro and Dapagliflozin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Lexapro and Dapagliflozin.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Pantoprazole and Ill-Defined Disorder - 2 seconds ago
- Samsca and Baby Aspirin drug interaction - 11 seconds ago
- Pantoprazole and Glomerulonephritis - 13 seconds ago
- Doxorubicin Hydrochloride and Xeloda drug interaction - 17 seconds ago
- Folic Acid and Extrasystoles - 20 seconds ago
- Megace and Fainting - 20 seconds ago
- Paxil and Mycoplasma Infection - 21 seconds ago
- Maxair and Burning Sensation - 22 seconds ago
- Cipro and Oedema Upper Limb - 28 seconds ago
- Norco and Systemic Lupus Erythematosus - 31 seconds ago